{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Holowatyj AN"],"funding":["NCATS NIH HHS","NHGRI NIH HHS","NCI NIH HHS"],"pagination":["217-225"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8064923"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(2)"],"pubmed_abstract":["<b><i>Purpose:</i></b> Rates of obesity and obesity-related health consequences, including type 2 diabetes (T2D) and cancer, continue to rise. While cancer patients are at an increased risk of developing T2D, the prevalence of T2D and insulin prescription among young patients with cancer remains unknown. <b><i>Methods:</i></b> Using the Total Cancer Care Study cohort at Huntsman Cancer Institute (Salt Lake City, UT), we identified individuals age 18-39 years at cancer diagnosis between 2009 and 2019. Multivariable logistic regression was used to investigate associations between body mass index (BMI) with insulin prescription within 1 year of cancer diagnosis. <b><i>Results:</i></b> In total, 344 adolescents and young adults (AYAs) were diagnosed with primary invasive cancer. Within this co"],"journal":["Journal of adolescent and young adult oncology"],"pubmed_title":["Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer."],"pmcid":["PMC8064923"],"funding_grant_id":["R01 CA189184","P30 CA042014","R01 CA207371","U01 CA206110","T32 HG008962","UL1 TR002538"],"pubmed_authors":["Holowatyj AN","Feltz S","Viskochil R","Wilson D","Larson M","Tingey B","Haaland B","Lewis MA","Colman H","Ose D","Ulrich CM"],"additional_accession":[]},"is_claimable":false,"name":"Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer.","description":"<b><i>Purpose:</i></b> Rates of obesity and obesity-related health consequences, including type 2 diabetes (T2D) and cancer, continue to rise. While cancer patients are at an increased risk of developing T2D, the prevalence of T2D and insulin prescription among young patients with cancer remains unknown. <b><i>Methods:</i></b> Using the Total Cancer Care Study cohort at Huntsman Cancer Institute (Salt Lake City, UT), we identified individuals age 18-39 years at cancer diagnosis between 2009 and 2019. Multivariable logistic regression was used to investigate associations between body mass index (BMI) with insulin prescription within 1 year of cancer diagnosis. <b><i>Results:</i></b> In total, 344 adolescents and young adults (AYAs) were diagnosed with primary invasive cancer. Within this co","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Apr","modification":"2025-04-29T11:34:58.82Z","creation":"2025-04-06T19:54:56.068Z"},"accession":"S-EPMC8064923","cross_references":{"pubmed":["32749900"],"doi":["10.1089/jayao.2020.0071"]}}